KaliVir Immunotherapeutics, Inc.
KaliVir Immunotherapeutics, Inc.

KaliVir Immunotherapeutics, Inc.

DR12Ahrefs DR: 12/100. Bottom 25%. Measured by Ahrefs. Median 44.eDR9Effective DR: 9/100. Bottom 25%. Measured by StartupHub.ai. Median 68.Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.Speed62Site Speed: 62/100. Above median. Measured by Google PageSpeed. Median 62.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Website
2019Active29Pittsburgh, United States

About

KaliVir Immunotherapeutics is a clinical-stage biotechnology company focused on developing innovative, multi-mechanistic oncolytic immunotherapy programs. The company leverages its proprietary Vaccinia Enhanced Template (VET™) platform to engineer vaccinia viruses that selectively replicate in and kill cancer cells, while also stimulating anti-tumor immunity and modifying the tumor microenvironment. Their product candidates are designed for systemic intravenous delivery to treat various cancer types.

Key facts

At-a-glance profile data

Website
kalivir.com
Headquarters
Pittsburgh, United States
Founded
2019
Employees
29
Total funding
$14M (Series A Extension)
Business model
B2B

Funding rounds

Funding rounds raised by KaliVir Immunotherapeutics, Inc.
DateRoundAmountLead investors
19 Aug 2026Series A Extension$14MCompany K Partners

Tech stack

Detected on kalivir.com, last scanned 23 Aug 2026. Run your own scan

Frontend
jQuery
SEO
All in One SEO
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Microsoft 365
Add first review

Frequently asked

What is KaliVir Immunotherapeutics, Inc.'s Effective Domain Rating?

StartupHub's Effective Domain Rating for KaliVir Immunotherapeutics, Inc. is 9 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is fairly rated against its Ahrefs Domain Rating of 10.

Is KaliVir Immunotherapeutics, Inc. trustworthy and reputable?

StartupHub's Data Trust & Reputation score for KaliVir Immunotherapeutics, Inc. is 52 out of 100, based on site security posture and privacy practices.

How much funding has KaliVir Immunotherapeutics, Inc. raised?

KaliVir Immunotherapeutics, Inc. has raised a total of $14M in funding. The most recent round on record is Series A Extension.

How many employees does KaliVir Immunotherapeutics, Inc. have?

KaliVir Immunotherapeutics, Inc. has approximately 29 people on record.